.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Farmers Insurance
McKesson
Baxter
AstraZeneca
Novartis
Boehringer Ingelheim
Daiichi Sankyo
QuintilesIMS

Generated: July 22, 2017

DrugPatentWatch Database Preview

GEREF Drug Profile

« Back to Dashboard

What is the patent landscape for Geref, and when can generic versions of Geref launch?

Geref is a drug marketed by Emd Serono Inc and Emd Serono and is included in two NDAs.

The generic ingredient in GEREF is sermorelin acetate. There is one drug master file entry for this compound. Additional details are available on the sermorelin acetate profile page.

Summary for Tradename: GEREF

Patents:0
Applicants:2
NDAs:2
Clinical Trials: see list2
Drug Prices:see details
DailyMed Link:GEREF at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997DISCNYesNo► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-002Sep 26, 1997DISCNYesNo► Subscribe► Subscribe
Emd Serono
GEREF
sermorelin acetate
INJECTABLE;INJECTION019863-001Dec 28, 1990DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: GEREF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono
GEREF
sermorelin acetate
INJECTABLE;INJECTION019863-001Dec 28, 19904,517,181► Subscribe
Emd Serono
GEREF
sermorelin acetate
INJECTABLE;INJECTION019863-001Dec 28, 19904,703,035► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 19974,517,181► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-002Sep 26, 19974,517,181► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-002Sep 26, 19974,703,035► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Medtronic
Citi
McKinsey
Teva
Merck
McKesson
Healthtrust
Queensland Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot